Neuroprotective and anti-inflammatory mechanisms are activated early in Optic Neuritis

被引:7
|
作者
Tsakiri, A. [1 ]
Ravanidis, S. [2 ]
Lagoudaki, R. [2 ]
Poulatsidou, K. -N. [2 ]
Svane, I. M. [3 ]
Frederiksen, J. L. [1 ]
Grigoriadis, N. [2 ]
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Glostrup, Denmark
[2] AHEPA Univ Hosp, Dept Neurol 2, Thessaloniki, Macedonia, Greece
[3] Univ Copenhagen, Herlev Hosp, Ctr Canc Immune Therapy, Dept Haematol & Oncol, DK-2730 Herlev, Denmark
来源
ACTA NEUROLOGICA SCANDINAVICA | 2015年 / 131卷 / 05期
关键词
cytokines; FOXP3; multiple sclerosis; optic neuritis; neurotrophic factors; REGULATORY T-CELLS; REMITTING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; DIAGNOSTIC-CRITERIA; INTERLEUKIN-10; DISEASE; BRAIN; SERUM;
D O I
10.1111/ane.12344
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - The aim of the study was to investigate the expression of different immunological mediators in blood and CSF in patients with acute ON and to estimate whether they were implicated in pro- or anti-inflammatory or even regulatory reactions in comparison with a healthy control group (HC). Methods - Sixty-four patients between 18 and 59 years of age suffering by acute ON, onset of <4 weeks, were included in the study. Visual tests and brain magnetic resonance imaging (MRI) were performed in ON. Blood and CSF samples were collected from untreated patients and from a gender-and age-matched voluntary HC (n = 32). The mRNA expression of distinct cytokines and neurotrophic factors was assessed by semi/quantitative real-time PCR (RT-PCR). Results - Brain- and glial cell-derived neurotrophic factor (BDNF and GDNF) and interleukin 10 (IL-10) expression was significantly increased in the CSF compared to the blood in both ON and HC (P < 0.001). In the CSF increased levels of BDNF and GDNF of the ON group were positively correlated with the presence of oligoclonal bands (OB). Additionally, patients with gadolinium (gd+) lesions on brain MRI showed increased levels of IL-5 in blood (P = 0.03). Conclusion - Our data indicate that both immunoregulatory and neuroprotective mechanisms may potentially take place relatively early in the course of the ON. The presence of neurotrophic factors in healthy CSF and their overexpression already during the acute phase of ON supports the alertness of CNS defence mechanisms ready to be activated during degenerative events, such as destruction of the myelin.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 50 条
  • [21] Anti-inflammatory and neuroprotective effects of GILZ analogs.
    Srinivasan, Mythily
    Chopra, Nipun
    Bayon, Baindu
    Lahiri, Debomoy
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [22] Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
    Nabavi, Seyed Fazel
    Braidy, Nady
    Gortzi, Olga
    Sobarzo-Sanchez, Eduardo
    Daglia, Maria
    Skalicka-Wozniak, Krystyna
    Nabavi, Seyed Mohammad
    BRAIN RESEARCH BULLETIN, 2015, 119 : 1 - 11
  • [23] Neuroprotective effects of calcitriol in autoimmune optic neuritis
    Suehs, K-W
    Pars, K.
    Williams, S. K.
    Hein, K.
    Diem, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 321 - 321
  • [24] Molecular Mechanisms of Anti-Inflammatory Phytochemicals
    Cruz-Martins, Natalia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [25] Radiobiological mechanisms of anti-inflammatory radiotherapy
    Trott, KR
    Kamprad, F
    RADIOTHERAPY AND ONCOLOGY, 1999, 51 (03) : 197 - 203
  • [26] Anti-Inflammatory Action and Mechanisms of Resveratrol
    Meng, Tiantian
    Xiao, Dingfu
    Muhammed, Arowolo
    Deng, Juying
    Chen, Liang
    He, Jianhua
    MOLECULES, 2021, 26 (01):
  • [27] Anti-inflammatory mechanisms in the vascular wall
    Tedgui, A
    Mallat, Z
    CIRCULATION RESEARCH, 2001, 88 (09) : 877 - 887
  • [28] Mechanisms of the Anti-inflammatory Action of Apocynin
    Houser, Kenneth Roy
    Johnson, David K.
    Ishmael, Faoud T.
    FASEB JOURNAL, 2011, 25
  • [29] MECHANISMS OF ACTION OF ANTI-INFLAMMATORY DRUGS
    BRUNE, K
    GLATT, M
    GRAF, P
    GENERAL PHARMACOLOGY, 1976, 7 (01): : 27 - &
  • [30] Anti-inflammatory mechanisms of leukotriene modulators
    Diamant, Z
    Sampson, AP
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (11): : 1449 - 1453